SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 375 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $263,396 | -20.4% | 2,300 | -4.2% | 0.01% | +44.4% |
| Q1 2023 | $330,792 | +41.4% | 2,400 | +74.8% | 0.01% | -43.8% |
| Q4 2020 | $234,000 | -15.8% | 1,373 | -72.5% | 0.02% | -86.8% |
| Q4 2018 | $278,000 | -48.6% | 5,000 | 0.0% | 0.12% | -14.2% |
| Q3 2018 | $541,000 | +118.1% | 5,000 | +166.8% | 0.14% | +60.2% |
| Q2 2018 | $248,000 | – | 1,874 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |